AI brief of an SEC Form 8-K · Eastman Chemical (EMN)

Eastman Q2 adjusted EPS rises to $1.97 on 10% sales gain; cash flow outlook lowered

Positive Impact 4 of 5 earnings Written later

Eastman reported second-quarter 2026 sales of $2,513 million, up 10% from $2,287 million a year earlier, with GAAP diluted EPS of $1.59 versus $1.20 and adjusted EPS of $1.97 versus $1.60. The company now expects 2026 operating cash flow to approach $900 million, modestly below its prior expectation of approaching 2025 levels, and projects third-quarter adjusted EPS to approach the $1.97 second-quarter level.

Key points

  • Second-quarter sales rose 10% to $2,513 million; Chemical Intermediates sales rose 39% while Fibers fell 11%
  • Adjusted EBIT rose to $320 million from $275 million; GAAP EBIT was $311 million versus $222 million
  • Operating cash flow was $224 million versus $233 million; full-year 2026 operating cash flow now expected to approach $900 million
  • Company expects third-quarter 2026 adjusted EPS to approach $1.97 and reaffirmed $125 million to $150 million of cost savings

The filing

CompanyEastman Chemical (EMN)
Form8-K, current report
Filed with the SECJul 30, 2026, 4:17 PM ET
Accession number0000915389-26-000138

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.